Receptor induction and targeted drug delivery: a new antileukaemia strategy

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Expert Opinion on Biological Therapy

• Publication date

  2003-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1517/14712598.3.4.563PMID 12831362
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of the folate receptor type beta gene by coordinate actions of retinoic acid receptors at activator Sp1/ets and repressor AP-1 sites.

  2003cited by this paper
• Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo

  2002cited by this paper
• Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical.

  2002cited by this paper
• Dual-specific T cells combine proliferation and antitumor activity

  2002cited by this paper
• Efficient intracellular delivery of oligonucleotides formulated in folate receptor-targeted lipid vesicles.

  2002cited by this paper
• Biodistribution of a 153Gd-Folate Dendrimer, Generation = 4, in Mice With Folate-Receptor Positive and Negative Ovarian Tumor Xenografts

  2002cited by this paper
• Evidence for Segregation of Heterologous GPI-anchored Proteins into Separate Lipid Rafts within the Plasma Membrane

  2002influential reference
• Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors

  2002cited by this paper
• Folate-mediated delivery of macromolecular anticancer therapeutic agents.

  2002cited by this paper
• Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors

  2002cited by this paper
• Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor

  2002cited by this paper
• Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid.

  2002influential reference
• Intracellular delivery of nanometric DNA particles via the folate receptor.

  2002cited by this paper
• Boron delivery to a murine lung carcinoma using folate receptor-targeted liposomes.

  2002cited by this paper
• Chloroaluminum phthalocyanine tetrasulfonate delivered via acid‐labile diplasmenylcholine‐folate liposomes: Intracellular localization and synergistic phototoxicity

  2001cited by this paper
• Pegylated doxorubicin for primary cutaneous T-cell lymphoma: a report on ten patients with follow-up

  2001cited by this paper
• Targeted drug delivery to chemoresistant cells: folic acid derivatization of FdUMP[10] enhances cytotoxicity toward 5-FU-resistant human colorectal tumor cells.

  2001cited by this paper
• Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer.

  2001cited by this paper
• Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin

  2001influential reference
• Folate-mediated targeting: from diagnostics to drug and gene delivery.

  2001cited by this paper
• Arsenic trioxide‐ and idarubicin‐induced remissions in relapsed acute promyelocytic leukaemia: Clinicopathological and molecular features of a pilot study

  2001cited by this paper
• Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia

  2001cited by this paper
• Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy

  2001cited by this paper
• Phase II Study of Liposomal Doxorubicin in Patients With Advanced Colorectal Cancer

  2001cited by this paper
• Conjugation of Folate via Gelonin Carbohydrate Residues Retains Ribosomal-inactivating Properties of the Toxin and Permits Targeting to Folate Receptor Positive Cells*

  2001cited by this paper
• Cytotoxicity of Anti-CD64-Ricin A Chain Immunotoxin Against Human Acute Myeloid Leukemia Cells In Vitro and in SCID Mice

  2001influential reference
• Optimal quality (131)I-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN.

  2001cited by this paper
• Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

  2001influential reference
• Folate-PEG-Folate-Graft-Polyethylenimine-Based Gene Delivery

  2001cited by this paper
• Cell Surface Receptor-Targeted Therapy of Acute Myeloid Leukemia: A Review

  2000cited by this paper
• Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies.

  2000influential reference
• Targeted drug delivery via the folate receptor.

  2000cited by this paper
• Selective targeting of immunoliposomal doxorubicin against human multiple myeloma in vitro and ex vivo.

  2000cited by this paper
• Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.

  2000cited by this paper
• Synthesis of [(99m)Tc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical.

  2000cited by this paper
• Liposome targeting to tumors using vitamin and growth factor receptors.

  2000cited by this paper
• High intratumoural accumulation of stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and in metastatic brain tumours

  2000cited by this paper
• Retinoids in chemoprevention and differentiation therapy.

  2000cited by this paper
• Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.

  2000cited by this paper
• Folate-targeted non-viral DNA vectors for cancer gene therapy.

  2000cited by this paper
• Differentiation-independent retinoid induction of folate receptor type beta, a potential tumor target in myeloid leukemia.

  2000influential reference
• Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublines

  2000cited by this paper
• Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.

  2000cited by this paper
• Design and synthesis of Cyclopenta[g]quinazoline-based antifolates as inhibitors of thymidylate synthase and potential antitumor agents(,).

  2000cited by this paper
• Phase II study of pegylated liposomal doxorubicin: inactive in recurrent small-cell lung cancer. A Hellenic Cooperative Oncology Group Study.

  2000cited by this paper
• Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2.

  2000cited by this paper
• DNA vaccination against the ovarian carcinoma-associated antigen folate receptor alpha (FRalpha) induces cytotoxic T lymphocyte and antibody responses in mice.

  1999cited by this paper
• Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer.

  1999cited by this paper
• In vitro cellular accumulation and cytotoxicity of liposomal and conventional formulations of daunorubicin and doxorubicin in resistant K562 cells.

  1999cited by this paper
• Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers.

  1999cited by this paper
• Adult acute myeloid leukaemia: update on treatment

  1999cited by this paper
• Complete Mapping of Divergent Amino Acids Responsible for Differential Ligand Binding of Folate Receptors α and β*

  1999cited by this paper
• Liposome‐encapsulated daunorubicin for PGP‐related multidrug resistance

  1999cited by this paper
• Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors.

  1999cited by this paper
• Expression and functional characterization of the beta-isoform of the folate receptor on CD34(+) cells.

  1999cited by this paper
• Expression of folate receptor type alpha in relation to cell type, malignancy, and differentiation in ovary, uterus, and cervix.

  1999influential reference
• Folate-targeted enzyme prodrug cancer therapy utilizing penicillin-V amidase and a doxorubicin prodrug.

  1999cited by this paper
• DNA vaccination against the ovarian carcinoma-associated antigen folate receptor α (FRα) induces cytotoxic T lymphocyte and antibody responses in mice

  1999cited by this paper
• Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study Group.

  1999cited by this paper
• Folate binding protein peptide 191-199 presented on dendritic cells can stimulate CTL from ovarian and breast cancer patients.

  1999cited by this paper
• Cytotoxic T lymphocyte response against non-immunoselected tumor antigens predicts the outcome of gene therapy with IL-12-transduced tumor cell vaccine

  1999cited by this paper
• Receptor-mediated targeting of 67Ga-deferoxamine-folate to folate-receptor-positive human KB tumor xenografts.

  1999cited by this paper
• Liposome encapsulated daunorubicin doubles anthracycline toxicity in cell lines showing a non-PGP related multidrug resistance.

  1999cited by this paper
• Modulation of multidrug resistance (MDR) in hematological malignancies.

  1999cited by this paper
• IL-4-transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer.

  1999cited by this paper
• Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis.

  1999influential reference
• Recognition of the carboxyl-terminal signal for GPI modification requires translocation of its hydrophobic domain across the ER membrane.

  1999cited by this paper
• Folate receptor type β is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia

  1999influential reference
• Anti‐HER2 Immunoliposomes for Targeted Drug Delivery

  1999cited by this paper
• Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond.

  1998influential reference
• Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity.

  1998influential reference
• IgG2a induced by interleukin (IL) 12-producing tumor cell vaccines but not IgG1 induced by IL-4 vaccine is associated with the eradication of experimental metastases.

  1998cited by this paper
• Structure and regulation of a polymorphic gene encoding folate receptor type gamma/gamma'.

  1998cited by this paper
• Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment.

  1998cited by this paper
• Liposomal drug formulations. Rationale for development and what we can expect for the future.

  1998cited by this paper
• Membrane receptors for endocytosis in the renal proximal tubule.

  1998cited by this paper
• Targeting of interleukin 2 to human ovarian carcinoma by fusion with a single-chain Fv of antifolate receptor antibody.

  1998cited by this paper
• Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

  1997influential reference
• Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor.

  1997cited by this paper
• Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein

  1997cited by this paper
• Anthracyclines in the treatment of cancer. An overview.

  1997cited by this paper
• Identification of amino acid residues that determine the differential ligand specificities of folate receptors alpha and beta.

  1997cited by this paper
• Overexpression of folate binding protein in ovarian cancers

  1997cited by this paper
• Chimeric bispecific OC/TR monoclonal antibody mediates lysis of tumor cells expressing the folate-binding protein (MOv18) and displays decreased immunogenicity in patients.

  1997cited by this paper
• Clustering of GPI-Anchored Folate Receptor Independent of Both Cross-Linking and Association with Caveolin

  1997cited by this paper
• Approaches to implement bispecific antibody treatment of ovarian carcinoma

  1997cited by this paper
• Expression levels of functional folate receptors alpha and beta are related to the number of N-glycosylated sites.

  1997cited by this paper
• Recombinant toxins containing human granulocyte-macrophage colony-stimulating factor and either pseudomonas exotoxin or diphtheria toxin kill gastrointestinal cancer and leukemia cells.

  1997influential reference
• Folate-maytansinoids: target-selective drugs of low molecular weight.

  1997cited by this paper
• Immunoliposomes for cancer treatment.

  1997cited by this paper
• Expression levels of functional folate receptors α and β are related to the number of N-glycosylated sites

  1997cited by this paper
• Folate‐maytansinoids: Target‐selective drugs of low molecular weight

  1997cited by this paper
• Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia.

  1996influential reference
• Enhanced delivery of synthetic oligonucleotides to human leukaemic cells by liposomes and immunoliposomes.

  1996cited by this paper
• CD3-CD28 costimulation as a means to avoiding T cell preactivation in bispecific monoclonal antibody-based treatment of ovarian carcinoma.

  1996cited by this paper
• Characterization of a hierarchy in human acute myeloid leukemia progenitor cells.

  1996cited by this paper
• Affinity liposomes in vivo: factors influencing target accumulation

  1996cited by this paper
• Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.

  1995cited by this paper
• Bispecific Antibody Targeted T Cell Therapy of Ovarian Cancer: Clinical Results and Future Directions

  1995cited by this paper
• Preferred sites of glycosylphosphatidylinositol modification in folate receptors and constraints in the primary structure of the hydrophobic portion of the signal.

  1995cited by this paper

• Mechanism of a Novel Complex: Zinc Oxide Nanoparticles-Luteolin to Promote Ferroptosis in Human Acute Myeloid Leukemia Cells in Vitro

  2025cites this paper
• Chemical potential and biomedical activity of gold nanoparticles in cancer and drug delivery systems: an updat

  2024cites this paper
• In vitro release and in vivo toxicity comparison studies between irinotecan and fullerene-biotin conjugated irinotecan

  2022cites this paper
• Development and Evaluation of Biotin Functionalized Fullerenes for the Delivery of Irinotecan to Colon Tumors.

  2022cites this paper
• Nanomicelles co-loading CXCR4 antagonist and doxorubicin combat the refractory acute myeloid leukemia.

  2022cites this paper
• Strategies for active tumor targeting-an update.

  2021cites this paper
• The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors

  2021cites this paper
• Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.

  2020cites this paper
• A novel fluorescence biosensor for the detection and imaging of tumor-related mRNA in living cells based on Au//hGNPs-FA nanocarrier

  2020cites this paper
• Gold nanoparticles regulate tight junctions and improve cetuximab effect in colon cancer cells.

  2019cites this paper
• Targeted drug delivery for tumor therapy inside the bone marrow.

  2018cites this paper
• A novel gene delivery composite system based on biodegradable folate-poly (ester amine) polymer and thermosensitive hydrogel for sustained gene release

  2016cites this paper
• Novel folate-targeted docetaxel-loaded nanoparticles for tumour targeting: in vitro and in vivo evaluation

  2016cites this paper
• Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression

  2015cites this paper
• Novel functions of folate receptor alpha in CNS development and diseases

  2014cites this paper
• Molecular mechanisms and physiology of disease

  2014cites this paper
• Nano-based drug delivery modalities for the treatment of cancer: The formulation of tumour-specific and-targeted nanoparticles

  2014cites this paper
• Development and Characterization of Multifunctional Nanoparticles for Drug Delivery to Cancer Cells

  2014cites this paper
• PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor.

  2013cites this paper
• Drug resistance to chlorambucil in murine B-cell leukemic cells is overcome by its conjugation to a targeting peptide

  2013cites this paper
• Gold nanoparticles: emerging paradigm for targeted drug delivery system.

  2013cites this paper
• Cancer Therapeutics- Opportunities, Challenges and Advances in Drug Delivery

  2011cites this paper
• Hormonal Control of Folate Receptor Genes

  2011cites this paper
• Gestational trophoblastic neoplasia, an ancient disease: new light and potential therapeutic targets.

  2010cites this paper
• Preparation of magnetite and tumor dual-targeting hollow polymer microspheres with pH-sensitivity for anticancer drug-carriers

  2010cites this paper
• Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil

  2010cites this paper
• Regulation of folate receptor internalization by protein kinase C alpha.

  2009cites this paper
• Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients.

  2009cites this paper
• Multi-functionalized single-walled carbon nanotubes as tumor cell targeting biological transporters

  2008cites this paper
• Active targeting schemes for nanoparticle systems in cancer therapeutics.

  2008cites this paper
• Folate-tethered emulsion for the target delivery of retinoids to cancer cells.

  2008cites this paper
• Ligand based dendritic systems for tumor targeting.

  2008cites this paper
• Folate Receptor as a Potential Delivery Route for Novel Folate Antagonists to Macrophages in the Synovial Tissue of Rheumatoid Arthritis Patients

  2008cites this paper
• Targeting DMARD resistance in Rheumatoid Arthritis

  2008cites this paper
• New mechanisms of transcriptional regulation of the folate receptor and other genes by steroid Receptors

  2007influential citation
• The folate receptor: What does it promise in tissue-targeted therapeutics?

  2007cites this paper
• Role of folate receptor genes in reproduction and related cancers.

  2006cites this paper
• Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates.

  2006cites this paper
• Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting.

  2005cites this paper
• Modulation of Folate Receptor-alpha by Glucocorticoid Receptor and Progesterone Receptor

  2005cites this paper
• Modulation of Folate Receptor Beta for Drug Targeting in Acute Myelogenous Leukemia

  2005cites this paper
• Sorting of the human folate receptor in MDCK cells.

  2004cites this paper
• Tumour-selective drug delivery via folate receptor-targeted liposomes

  2004influential citation
• Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy.

  2004cites this paper